Evidence map›Paper›PMID 18415698›Full record

ReviewJournal of inherited metabolic disease2008

Inherited epithelial transporter disorders--an overview.

M J Bergeron, A Simonin, M Bürzle, M A Hediger

Abstract readReview
PubMed Publisher
In one paragraph

Review in Journal of inherited metabolic disease, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Emerging Roles in the Biogenesis of CytochromeFrontiers in cell and developmental biology · 2019
    Review
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

M J BergeronInstitute of Biochemistry and Molecular Medicine, University of Berne, Berne, Switzerland.
A Simonin
M Bürzle
M A Hediger

Funding

Canadian Institutes of Health Research
6 · The paper itself

Abstract

In the late 1990s, the identification of transporters and transporter-associated genes progressed substantially due to the development of new cloning approaches such as expression cloning and, subsequently, to the implementation of the human genome project. Since then, the role of many transporter genes in human diseases has been elucidated. In this overview, we focus on inherited disorders of epithelial transporters. In particular, we review genetic defects of the genes encoding glucose transporters (SLC2 and SLC5 families) and amino acid transporters (SLC1, SLC3, SLC6 and SLC7 families).

Indexed as

Amino AcidsAmino Acid Transport Disorders, InbornAmino Acid Transport SystemsAnimalsCarbohydrate Metabolism, Inborn ErrorsEpithelial CellsGenetic Predisposition to DiseaseGlucoseHumansMonosaccharide Transport ProteinsPhenotypeSodium-Glucose Transport ProteinsAmino AcidsAmino Acid Transport SystemsGlucoseMonosaccharide Transport ProteinsSodium-Glucose Transport Proteins

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.